Increased frequency of ICOS(+) CD4 T-cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy

Pharmacodynamic biomarkers can play an important role in understanding whether a therapeutic agent has “hit its target” to impact biologic function. A pharmacodynamic biomarker for anti-CTLA-4 therapy remains to be elucidated. We previously reported that anti-CTLA-4 therapy increases the frequency o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Immunol Res
Main Authors: Tang, Derek Ng, Shen, Yu, Sun, Jingjing, Wen, Sijin, Wolchok, Jedd D., Yuan, Jianda, Allison, James P., Sharma, Padmanee
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636341/
https://ncbi.nlm.nih.gov/pubmed/24777852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-13-0020
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares